XML 53 R36.htm IDEA: XBRL DOCUMENT
v3.25.3

Description of Business (Tables) | 12 Months Ended
--- | ---
Jul. 31, 2025
Description of Business [Abstract] |
Schedule of Consolidated Financial Statements | All majority-owned subsidiaries and RP Finance, LLC are consolidated with all intercompany transactions and balances eliminated in consolidation. In addition to Rafael Holdings, Inc., the entities included in these consolidated financial statements are as follows:
Company |  | Country of Incorporation |  | Percentage Owned
Broad Atlantic Associates, LLC |  | United States – Delaware |  | 100 %
IDT R.E. Holdings Ltd. |  | Israel |  | 100 %
Rafael Holdings Realty, Inc. |  | United States – Delaware |  | 100 %
Barer Institute, Inc. |  | United States – Delaware |  | 100%*
Hillview Avenue Realty, JV |  | United States – Delaware |  | 100 %
Hillview Avenue Realty, LLC |  | United States – Delaware |  | 100 %
Rafael Medical Devices, LLC |  | United States – Delaware |  | 73 %
Farber Partners, LLC |  | United States – Delaware |  | 93 %
Pharma Holdings, LLC |  | United States – Delaware |  | 90%**
LipoMedix Pharmaceuticals Ltd. (Note 12) |  | Israel |  | 95 %
Altira Capital & Consulting, LLC |  | United States – Delaware |  | 67 %
CS Pharma Holdings, LLC (Note 7) |  | United States – Delaware |  | 45%**
Day Three Labs, Inc. (Note 13) |  | United States – Delaware |  | 84 %
Cornerstone Pharmaceuticals, Inc. (Note 6) |  | United States – Delaware |  | 67 %
RP Finance, LLC (Note 8) |  | United States – Delaware |  | 38 %
Cyclo Therapeutics, LLC (Note 3) |  | United States – Nevada |  | 100 %
| * | In November 2022, the Company resolved to curtail its early-stage development efforts, including pre-clinical research at Barer. The decision was taken to reduce spending as the Company focuses on exploring strategic opportunities.
| ** | 50% of CS Pharma Holdings, LLC is owned by Pharma Holdings, LLC. We have a 90% ownership interest in Pharma Holdings, LLC and, therefore, an effective 45% economic interest in CS Pharma Holdings, LLC. The Company, along with CS Pharma Holdings, LLC and Pharma Holdings LLC, collectively own securities representing 67% of the outstanding capital stock of Cornerstone.

X
- References No definition available. + Details
Name: | us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the key aspects of a subsidiary (partnership, corporation, or other entity) of the limited liability company or limited partnership. + References No definition available. + Details
Name: | us-gaap_ScheduleOfSubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipDescriptionTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration